Free Market Health, a 4-year-old Strip District prescription drug technology marketplace, has raised $20 million in a Series B investment round, and the latest success of a Pittsburgh life sciences startup in a tough environment for venture capital.
San Francisco-based Questa Capital, a health care venture capital firm, led the round with participation from existing investors Alta Partners, Highmark Ventures and 653 Investment Partners. The new funds will fuel business growth, launch channel partnership opportunities and scale the company’s specialty pharmacy marketplace.
“Free Market Health was founded with a mission to never let the process fail the patient and our results to date coupled with this latest investment are validation that we are making a real difference,” founder and CEO Joe Cardosi said in a prepared statement.
Free Market operates an online marketplace that matches member specialty prescription needs with in-network specialty drugstores, allowing them to bid on filling prescriptions. On Tuesday, Uptown-based biotech startup Imagine Pharma announced a $32.5 million fund raise while cancer nanomedicine developer Duo Oncology, based in Hazelwood Green, was recently awarded a federal Small Business Technology Transfer grant to develop the company’s second therapy for cancer.
Mr. Cardosi received his pharmacy degree and an MBA from Duquesne University and founded the company in 2019. Hospital and health insurance giant Highmark Health and its subsidiary Highmark Wholecare are among Free Market’s clients.
Highmark Wholecare has realized prescription drug savings of $2 per member per month since starting to use the Free Market platform in 2021, according to the company. Free Market’s digital platform handles more than 200,000 specialty drug claims annually, which is an increase of nearly 400% annually.
Kris B. Mamula: kmamula@post-gazette.com




Comments
Welcome to Post-Gazette subscriber-only commenting community. Please review our community guidelines.